Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) Vol. 134; no. 21; pp. e468 - e495
Main Authors: Wiggins, Barbara S, Saseen, Joseph J, Page, Robert L, Reed, Brent N, Sneed, Kevin, Kostis, John B, Lanfear, David, Virani, Salim, Morris, Pamela B
Format: Journal Article
Language:English
Published: United States by the American College of Cardiology Foundation and the American Heart Association, Inc 22-11-2016
Subjects:
immunosuppressive agents
cardiovascular disease
calcium channel blockers
anticoagulants
anti-arrhythmic agents
hydroxymethylglutaryl-CoA reductase inhibitors
drug-related side effects and adverse reactions
gemfibrozil
fenofibrate/fenofibric acid derivatives
AHA Scientific Statements
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-3
ObjectType-Feature-4
content type line 23
ObjectType-Review-1
ISSN:0009-7322
1524-4539
DOI:10.1161/CIR.0000000000000456